143 related articles for article (PubMed ID: 20451671)
21. BRCT domain interactions in the heterodimeric DNA repair protein XRCC1-DNA ligase III.
Dulic A; Bates PA; Zhang X; Martin SR; Freemont PS; Lindahl T; Barnes DE
Biochemistry; 2001 May; 40(20):5906-13. PubMed ID: 11352725
[TBL] [Abstract][Full Text] [Related]
22. Function of BRCA1 in the DNA damage response is mediated by ADP-ribosylation.
Li M; Yu X
Cancer Cell; 2013 May; 23(5):693-704. PubMed ID: 23680151
[TBL] [Abstract][Full Text] [Related]
23. BRCA1-dependent and independent functions of BARD1.
Irminger-Finger I; Leung WC
Int J Biochem Cell Biol; 2002 Jun; 34(6):582-7. PubMed ID: 11943588
[TBL] [Abstract][Full Text] [Related]
24. Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1.
Williams RS; Lee MS; Hau DD; Glover JN
Nat Struct Mol Biol; 2004 Jun; 11(6):519-25. PubMed ID: 15133503
[TBL] [Abstract][Full Text] [Related]
25. Estrogen receptor alpha is a putative substrate for the BRCA1 ubiquitin ligase.
Eakin CM; Maccoss MJ; Finney GL; Klevit RE
Proc Natl Acad Sci U S A; 2007 Apr; 104(14):5794-9. PubMed ID: 17392432
[TBL] [Abstract][Full Text] [Related]
26. Functional Analysis of BARD1 Missense Variants in Homology-Directed Repair of DNA Double Strand Breaks.
Lee C; Banerjee T; Gillespie J; Ceravolo A; Parvinsmith MR; Starita LM; Fields S; Toland AE; Parvin JD
Hum Mutat; 2015 Dec; 36(12):1205-14. PubMed ID: 26350354
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of BRCA1-BARD1 ubiquitin ligase by CDK2.
Hayami R; Sato K; Wu W; Nishikawa T; Hiroi J; Ohtani-Kaneko R; Fukuda M; Ohta T
Cancer Res; 2005 Jan; 65(1):6-10. PubMed ID: 15665273
[TBL] [Abstract][Full Text] [Related]
28. BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sites.
Hu Z; Mi S; Zhao T; Peng C; Peng Y; Chen L; Zhu W; Yao Y; Song Q; Li X; Li X; Jia C; Pei H
EMBO J; 2020 Jun; 39(12):e104133. PubMed ID: 32347575
[TBL] [Abstract][Full Text] [Related]
29. Structural insight into BRCA1-BARD1 complex recruitment to damaged chromatin.
Dai L; Dai Y; Han J; Huang Y; Wang L; Huang J; Zhou Z
Mol Cell; 2021 Jul; 81(13):2765-2777.e6. PubMed ID: 34102105
[TBL] [Abstract][Full Text] [Related]
30. BARD1: an independent predictor of survival in non-small cell lung cancer.
Zhang YQ; Bianco A; Malkinson AM; Leoni VP; Frau G; De Rosa N; André PA; Versace R; Boulvain M; Laurent GJ; Atzori L; Irminger-Finger I
Int J Cancer; 2012 Jul; 131(1):83-94. PubMed ID: 21815143
[TBL] [Abstract][Full Text] [Related]
31. The BRCT Domains of the BRCA1 and BARD1 Tumor Suppressors Differentially Regulate Homology-Directed Repair and Stalled Fork Protection.
Billing D; Horiguchi M; Wu-Baer F; Taglialatela A; Leuzzi G; Nanez SA; Jiang W; Zha S; Szabolcs M; Lin CS; Ciccia A; Baer R
Mol Cell; 2018 Oct; 72(1):127-139.e8. PubMed ID: 30244837
[TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of missense alterations in the BRCA1 associated RING domain (BARD1) gene in breast and ovarian cancer.
Sauer MK; Andrulis IL
J Med Genet; 2005 Aug; 42(8):633-8. PubMed ID: 16061562
[TBL] [Abstract][Full Text] [Related]
33. Re-engineering a split-GFP reassembly screen to examine RING-domain interactions between BARD1 and BRCA1 mutants observed in cancer patients.
Sarkar M; Magliery TJ
Mol Biosyst; 2008 Jun; 4(6):599-605. PubMed ID: 18493658
[TBL] [Abstract][Full Text] [Related]
34. A truncated splice variant of human BARD1 that lacks the RING finger and ankyrin repeats.
Tsuzuki M; Wu W; Nishikawa H; Hayami R; Oyake D; Yabuki Y; Fukuda M; Ohta T
Cancer Lett; 2006 Feb; 233(1):108-16. PubMed ID: 15878232
[TBL] [Abstract][Full Text] [Related]
35. Distinct roles of BARD1 isoforms in mitosis: full-length BARD1 mediates Aurora B degradation, cancer-associated BARD1beta scaffolds Aurora B and BRCA2.
Ryser S; Dizin E; Jefford CE; Delaval B; Gagos S; Christodoulidou A; Krause KH; Birnbaum D; Irminger-Finger I
Cancer Res; 2009 Feb; 69(3):1125-34. PubMed ID: 19176389
[TBL] [Abstract][Full Text] [Related]
36. The UBXN1 protein associates with autoubiquitinated forms of the BRCA1 tumor suppressor and inhibits its enzymatic function.
Wu-Baer F; Ludwig T; Baer R
Mol Cell Biol; 2010 Jun; 30(11):2787-98. PubMed ID: 20351172
[TBL] [Abstract][Full Text] [Related]
37. Docking and Molecular Dynamics Simulation Revealed the Potential Inhibitory Activity of Amygdalin in Triple-Negative Breast Cancer Therapeutics Targeting the BRCT Domain of BARD1 Receptor.
Chatterjee P; Karn R; Emerson IA; Banerjee S
Mol Biotechnol; 2024 Apr; 66(4):718-736. PubMed ID: 36732462
[TBL] [Abstract][Full Text] [Related]
38. In silico investigation on the mutational analysis of BRCA1-BARD1 RING domains and its effect on nucleosome recognition and ubiquitination.
Sarma H; Kiewhuo K; Jamir E; Sastry GN
Biophys Chem; 2023 Sep; 300():107070. PubMed ID: 37339533
[TBL] [Abstract][Full Text] [Related]
39. BRCA1-BARD1 Regulates Axon Regeneration in Concert with the Gqα-DAG Signaling Network.
Sakai Y; Hanafusa H; Shimizu T; Pastuhov SI; Hisamoto N; Matsumoto K
J Neurosci; 2021 Mar; 41(13):2842-2853. PubMed ID: 33593852
[TBL] [Abstract][Full Text] [Related]
40. Interactions between BRCT repeats and phosphoproteins: tangled up in two.
Glover JN; Williams RS; Lee MS
Trends Biochem Sci; 2004 Nov; 29(11):579-85. PubMed ID: 15501676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
